FDA approves new treatment of metastatic melanoma.
作者信息
Printz Carrie
出版信息
Cancer. 2016 Apr 15;122(8):1149. doi: 10.1002/cncr.29998.
PMID:27061518
Abstract
摘要
相似文献
1
FDA approves new treatment of metastatic melanoma.
Cancer. 2016 Apr 15;122(8):1149. doi: 10.1002/cncr.29998.
2
[Immunotherapy in the treatment of advanced or metastatic melanoma: nivolumab from phase I studies to approvement by European Medicines Agency].
Recenti Prog Med. 2015 Dec;106(12):608-17. doi: 10.1701/2094.22650.
3
Cutaneous melanoma: available therapy for metastatic disease.
Dermatol Ther. 2006 Jan-Feb;19(1):19-25. doi: 10.1111/j.1529-8019.2005.00052.x.
4
Spotlight on pembrolizumab in the treatment of advanced melanoma.
Drug Des Devel Ther. 2015 Jun 4;9:2883-6. doi: 10.2147/DDDT.S78036. eCollection 2015.
5
Melanoma treatment's changing landscape.
J Natl Cancer Inst. 2014 Jun 6;106(6):dju176. doi: 10.1093/jnci/dju176. Print 2014 Jun.
6
High neutrophil-to-lymphocyte ratio before starting anti-programmed cell death 1 immunotherapy predicts poor outcome in patients with metastatic melanoma.
J Am Acad Dermatol. 2018 Jul;79(1):165-167.e2. doi: 10.1016/j.jaad.2018.03.006. Epub 2018 Mar 12.
7
Ipilimumab approved for metastatic melanoma.
Am J Health Syst Pharm. 2011 May 1;68(9):768. doi: 10.2146/news110025.
8
FDA approves new melanoma treatments.
Johns Hopkins Med Lett Health After 50. 2012 Jan;23(11):3.
9
FDA approves two new drugs against advanced melanoma.
Am J Health Syst Pharm. 2013 Jul 1;70(13):1094. doi: 10.2146/news130045.
10
NICE guidance on ipilimumab for treating previously untreated advanced (unresectable or metastatic) melanoma.
Lancet Oncol. 2014 Sep;15(10):1056-7. doi: 10.1016/s1470-2045(14)70341-9.
引用本文的文献
1
Oncolytic viruses for triple negative breast cancer and beyond.
Biomark Res. 2021 Sep 25;9(1):71. doi: 10.1186/s40364-021-00318-4.
2
Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders.
Front Genet. 2019 Sep 25;10:868. doi: 10.3389/fgene.2019.00868. eCollection 2019.
Zotero 插件